Streptozotocin-Induced Autophagy Reduces Intracellular Insulin in Insulinoma INS-1E Cells.

DNA and Cell Biology
Yeong-Min Yoo, Yung Chul Park

Abstract

Streptozotocin (STZ), a glucose analog, induces diabetes in experimental animals by inducing preferential cytotoxicity in pancreatic beta cells. We investigated whether STZ reduced the production of intracellular insulin through autophagy in insulinoma INS-1E cells. Typically, 2 mM STZ treatment for 24 h significantly decreased cell survival. STZ treatment led to significant decrease in phospho-AMP-activated protein kinase (p-AMPK) level; reduction in levels of phospho-protein kinase R-like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme 1α (IRE1α); significant reduction in levels of p85α, p110, phospho-serine and threonine kinase/protein kinase B (p-Akt/PKB) (Ser473), phospho-extracellular-regulated kinase (p-ERK), and phospho-mammalian target of rapamycin (p-mTOR); increase in levels of Cu/Zn-superoxide dismutase (SOD), Mn-SOD, and catalase; decrease in B-cell lymphoma 2 (Bcl-2) expression; increase in Bcl-2-associated X protein (Bax) expression; increase in levels of microtubule-associated protein 1 light chain 3 (LC3) and Beclin 1; and reduction in production of intracellular insulin. These results suggest that insulin synthesis during STZ treatment involves autophagy in INS-1E cells and, subsequently, res...Continue Reading

References

Feb 21, 1997·Cell·T F FrankeL C Cantley
Oct 1, 1998·Journal of Pineal Research·P L MontillaE S Cabrera
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A A PieperS H Snyder
Mar 23, 1999·Biochemical Pharmacology·M MurataS Kawanishi
Dec 20, 2003·Biochemical and Biophysical Research Communications·Chiharu TokunagaKazuyoshi Yonezawa
Jan 27, 2006·The EMBO Journal·Zaira GarcíaAna C Carrera
Feb 9, 2007·The Journal of Biological Chemistry·Catherine E GleasonMorris J Birnbaum
May 15, 2007·Oncogene·M RamanM H Cobb
Jun 21, 2007·Molecular Endocrinology·Brad J MarshChristopher J Rhodes
Aug 7, 2009·Autophagy·Piero Marchetti, Matilde Masini
Feb 24, 2010·Molecular and Cellular Endocrinology·Hwanju CheonMyung-Shik Lee
Oct 5, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M TanemuraY Doki
Dec 25, 2013·Journal of Diabetes and Metabolic Disorders·Chinedum Ogbonnaya EleazuUdeme Nelson Essien
Jul 24, 2014·Metallomics : Integrated Biometal Science·Hyae-Ran ByunJae-Young Koh
Jun 23, 2015·Journal of Receptor and Signal Transduction Research·Yu SunHua-Fu Zhou
Apr 14, 2016·International Journal of Molecular Sciences·Yeong-Min YooHan Sung Kim
Aug 19, 2016·Data in Brief·Han Sung Kim, Yeong-Min Yoo
Sep 13, 2016·Diabetes, Obesity & Metabolism·A HelmanY Dor

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
X-ray
glycosylation

Software Mentioned

GraphPad
Prism GraphPad
ImageJ

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.